A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy

NCT00283504 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

ALLERGIC ASTHMA

Interventions

DRUG: ANTI-IGE THERAPY (XOLAIR)

Sponsor

Children's Hospital of The King's Daughters

Collaborators

[object Object]
[object Object]